Laryngeal soft tissue sarcoma: Systematic review and individual patient data analysis of 300 cases.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
05 2021
Historique:
revised: 18 12 2020
received: 18 06 2020
accepted: 29 12 2020
pubmed: 16 1 2021
medline: 1 7 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

Laryngeal sarcoma is rare. We performed a systematic review and individual patient analysis to evaluate the patterns of care, prognostic factors, and role of radiotherapy in laryngeal soft tissue sarcoma. A systematic search on PubMed and Google scholar was done. An individual patient data analysis was done. Of the 300 cases of laryngeal sarcoma, 80% underwent surgery. 44% underwent larynx preservation surgery and 25% received radiotherapy with surgery. Median progression free survival (PFS) was 48 months and overall survival (OS) of 224 months for the entire cohort. Patients with large primary, cartilage invasion, and positive margins had numerically worse PFS. Cartilage invasion and primary tumor size >3 cm were the most common risk factors for adjuvant radiation therapy. Patients receiving radiotherapy were not associated with better survival. Laryngeal sarcoma associated with a good survival. Larynx preservation surgery is feasible in nearly half patients. Adjuvant radiotherapy may be warranted in patients poor prognostic factors.

Sections du résumé

BACKGROUND
Laryngeal sarcoma is rare. We performed a systematic review and individual patient analysis to evaluate the patterns of care, prognostic factors, and role of radiotherapy in laryngeal soft tissue sarcoma.
METHODS
A systematic search on PubMed and Google scholar was done. An individual patient data analysis was done.
RESULTS
Of the 300 cases of laryngeal sarcoma, 80% underwent surgery. 44% underwent larynx preservation surgery and 25% received radiotherapy with surgery. Median progression free survival (PFS) was 48 months and overall survival (OS) of 224 months for the entire cohort. Patients with large primary, cartilage invasion, and positive margins had numerically worse PFS. Cartilage invasion and primary tumor size >3 cm were the most common risk factors for adjuvant radiation therapy. Patients receiving radiotherapy were not associated with better survival.
CONCLUSION
Laryngeal sarcoma associated with a good survival. Larynx preservation surgery is feasible in nearly half patients. Adjuvant radiotherapy may be warranted in patients poor prognostic factors.

Identifiants

pubmed: 33448036
doi: 10.1002/hed.26604
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1421-1427

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Eeles RA, Fisher C, A'Hern RP, et al. Headand neck sarcomas: prognostic factors and implications for treatment. Br J Cancer. 1993;68(1):201-207.
Casali PG, Blay J-Y. Soft tissue sarcomas: ESMO clinical practice guidelines fordiagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl. 5):v198-v203.
Skoulakis CE, Stavroulaki P, Moschotzopoulos P, Paxinos M, Fericean A, Valagiannis DE. Laryngeal leiomyosarcoma: a case report and review of literature. Eur Arch Otorhinolaryngol. 2006;263:929-934.
Adeyemi BF, Adekunle LV, Kolude BM, Akang EEU, Lawoyin JO. Head and neck cancer - a clinicopathological study in a tertiary care centre. J Natl Med Assoc. 2008;100:690-697.
Gilyoma JM, Rambau PF, Masalu N, Kayange NM, Chalya PL. Head and neck cancers: a clinic-pathological profile and management challenges in a resource- limited setting. BMC Res Notes. 2015;8:772.
Gu J, Zuo Z, Sun L, Li L, Zhao N. Prognostic factors for laryngeal sarcoma and nomogram development for prediction: a retrospective study based on SEER database. Ann Transl Med. 2020;8(8):545.
Mantilla JG, Xu H, Ricciotti RW. Primary sarcomas of the larynx: a single institutional experience with ten cases. Head and Neck Pathol. 2020;14:707-714.
Karatayli-Ozgursoy S, Bishop JA, Hillel AT, et al. Non-epithelial tumors of the larynx: a single institution review. Am J Otolaryngol. 2016;37:279-285.

Auteurs

Anjali V Ramdulari (AV)

Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.

Yousra Izzuddeen (Y)

Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.

Rony Benson (R)

Department of Medical Oncology, Regional Cancer Centre, Trivandrum, India.

Supriya Mallick (S)

Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, Badsa, India.

Bhanuprasad Venkatesulu (B)

Department of Internal Medicine, Henry Ford Hospital, Detroit, USA.

Prashanth Giridhar (P)

Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, Badsa, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH